Physician

Samuel Chan Kim, MD

According to 2025 Medicare claims, Samuel Kim, MD (NPI: 1134129679) practices urology in the Muncie, IN market, with the plurality of this provider's patient population coming from Delaware, IN. This provider's primary affiliated billing organization is INDIANA UNIVERSITY HEALTH BALL MEMORIAL PHYSICIANS, INC. (NPI: 1235455544; TIN: 351925641) and primary practice location at 47304-3988. Kim is affiliated with the Indiana University Health ACO, Inc. (ACO ID: D0034), participating under the REACH model.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 339 traditional Medicare patients, billed 1,346 HCPCS/CPT codes, and received $103,821 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,208 prescription claims across 384 beneficiaries totaling $75,253 in drug costs, led by Gemtesa (Vibegron). DME data shows 31 claims. Open Payments data shows 2 records totaling $105. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $279,061 to $103,821. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $237,017 and ending at $75,253. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	925	10,046	$279,061
2016	941	7,340	$246,345
2017	1,060	9,326	$290,332
2018	1,139	10,189	$322,000
2019	1,083	6,956	$278,476
2020	916	5,462	$211,555
2021	897	8,094	$214,103
2022	650	4,508	$145,556
2023	120	244	$25,045
2024	339	1,346	$103,821

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	525	1,963	$237,017
2016	563	2,167	$283,448
2017	649	2,430	$190,233
2018	692	2,577	$473,453
2019	770	2,985	$512,773
2020	713	3,040	$441,947
2021	776	2,566	$294,015
2022	687	2,791	$351,320
2023	262	515	$62,655
2024	384	1,208	$75,253

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	63	$7,620
2016	N/R	65	$9,775
2017	15	99	$11,235
2018	31	166	$30,774
2019	32	164	$26,525
2020	31	191	$26,722
2021	21	135	$24,730
2022	13	124	$30,238
2023	N/R	48	$11,200
2024	N/R	31	$7,994

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	90	90	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	173	248	$95
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	170	210	$13
51798	Ultrasound measurement of bladder capacity after voiding	109	138	$8
81003	Automated urinalysis test	62	67	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	26	1,420	$22,289
Myrbetriq	Mirabegron	21	1,321	$18,617
Trospium Chloride	Trospium Chloride	95	5,577	$5,918
Tamsulosin Hcl	Tamsulosin Hcl	248	17,264	$4,308
Tolterodine Tartrate Er	Tolterodine Tartrate	16	1,245	$2,306

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	31	$7,994

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$105	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Samuel Chan Kim, MD?

Tedicare shows public-source Medicare data for Samuel Chan Kim, MD (NPI 1134129679), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel Chan Kim, MD have ACO affiliation data?

Samuel Chan Kim, MD is shown with ACO affiliation data for Indiana University Health ACO, Inc. (REACH, ACO ID D0034).

What billing organization is linked to Samuel Chan Kim, MD?

Samuel Chan Kim, MD is linked to INDIANA UNIVERSITY HEALTH BALL MEMORIAL PHYSICIANS, INC. (billing NPI 1235455544) in the available physician profile data.

Does Samuel Chan Kim, MD have Open Payments data?

Samuel Chan Kim, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.